Related Experiment Video

Updated: Oct 29, 2025

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.5K

Immune-Mediated Sensorineural Hearing Loss in the Pediatric Population

Scott Gorthey1,2, Ravi Patel1, Andrea Vambutas1,2,3

  • 1Department of Otolaryngology, Hofstra-Northwell School of Medicine, New Hyde Park, New York, USA.

Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|July 13, 2021
PubMed

Insights

Pediatric immune-mediated sensorineural hearing loss (SNHL) shows a significant corticosteroid response rate, similar to adults. Prompt treatment is crucial for sustained hearing improvement in children with SNHL.

Area of Science:

  • Otolaryngology
  • Immunology
  • Pediatrics

Background:

  • Immune-mediated sensorineural hearing loss (SNHL) is a recognized condition in both pediatric and adult populations.
  • Treatment strategies for pediatric SNHL often involve corticosteroids, but response rates require further elucidation.
  • Understanding the efficacy of corticosteroids in pediatric immune-mediated SNHL is critical for optimizing treatment protocols.

Purpose of the Study:

  • To evaluate the corticosteroid response rate in pediatric patients diagnosed with immune-mediated sensorineural hearing loss.
  • To assess the sustained response to multiple courses of corticosteroids for recurrent or progressive hearing loss in this cohort.
  • To determine the impact of timely corticosteroid treatment on outcomes in pediatric immune-mediated SNHL.

Main Methods:

  • A retrospective case series and chart review was conducted.
  • Included were 41 pediatric patients with sensorineural hearing loss who received corticosteroid therapy.
  • Primary outcome: corticosteroid response rate. Secondary outcome: sustained response with multiple treatments.

Main Results:

  • The overall corticosteroid response rate in pediatric patients was 61%.
  • A sustained response was observed in 57% of patients receiving multiple corticosteroid courses.
  • Prompt corticosteroid treatment was associated with a higher likelihood of both initial and sustained response.

Conclusions:

  • Pediatric immune-mediated sensorineural hearing loss demonstrates a corticosteroid responsiveness comparable to adult counterparts.
  • Corticosteroid therapy should be strongly considered for pediatric immune-mediated SNHL.
  • Timely intervention is paramount for achieving optimal and sustained hearing outcomes in affected children.

Keywords:
autoimmune inner ear diseasepediatric hearing losssudden sensorineural hearing loss

More Related Videos

Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages09:09

Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages

Published on: April 11, 2025

1.1K
Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses14:05

Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses

Published on: January 23, 2017

29.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
45
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
47
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
59